Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis - Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Department of Infectious Diseases and Infection Control, Jikei University School of Medicine0 个研究点目标入组 20 人开始时间: 2010年7月31日最近更新: 2023年10月17日

试验速览

暂无简介。

•1)patient detected N.gonorrhoeae by microscopic examination or bacteriological examination etc. 2)patient who has been administered other antibiotics and his symptom has been improved before starting administration of the study drug 3)patient administered fluoroquinolone within a week before starting administration of the study drug 4)patient with severe infection desease, who cannot be expected efficacy of oral administration therapy 5)patient with severe underlying disease or complications, who cannot be evaluated efficacy and safety of the study drug 6)patient with a history of fluoroquinolone allergies 7)patient with severe cardiac or hepatic dysfunction 8)patient with moderate renal dysfunction (Criteria: Serum Creatinine >= 2mg/dL) 9)patient with convulsive disorders like epilepsy or with a history of these deseases 10)patient disqualified as target by doctor

发起方

Department of Infectious Diseases and Infection Control, Jikei University School of Medicine